Page last updated: 2024-10-30

lansoprazole and Aberrant Tissue

lansoprazole has been researched along with Aberrant Tissue in 3 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, X1
Tsukamoto, T1
Nozaki, K1
Shimizu, N1
Mizoshita, T1
Kumagai, T1
Kaminishi, M1
Tatematsu, M1
Bender, E1
Schmidt, SP1
Cuddihy, PJ1
Maheshwar, A1
Griffith, H1

Other Studies

3 other studies available for lansoprazole and Aberrant Tissue

ArticleYear
Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils.
    Cancer science, 2004, Volume: 95, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Apoptosis; Cel

2004
Extraintestinal heterotopic gastric tissue simulating acute appendicitis.
    World journal of gastroenterology, 2008, Apr-14, Volume: 14, Issue:14

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Acute Disease; Aged; Appendicitis; Choristo

2008
Symptomatic heterotopic gastric mucosa in the upper oesophagus.
    The Journal of laryngology and otology, 1998, Volume: 112, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Choristoma; Cimetidine; Esophageal Disea

1998